These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16114571)

  • 41. Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia.
    Abeling NG; Duran M; Bakker HD; Stroomer L; Thöny B; Blau N; Booij J; Poll-The BT
    Mol Genet Metab; 2006; 89(1-2):116-20. PubMed ID: 16650784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe tongue protrusion dystonia: clinical syndromes and possible treatment.
    Schneider SA; Aggarwal A; Bhatt M; Dupont E; Tisch S; Limousin P; Lee P; Quinn N; Bhatia KP
    Neurology; 2006 Sep; 67(6):940-3. PubMed ID: 17000958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autosomal-dominant guanosine triphosphate cyclohydrolase I deficiency with novel mutations.
    Yum MS; Ko TS; Yoo HW; Chung SJ
    Pediatr Neurol; 2008 May; 38(5):367-9. PubMed ID: 18410856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Late onset dopa-responsive dystonia with tremor, gait freezing and behavioural disturbance and a normal dopamine transporter scan.
    Harper A; Bayliss M; Saha R; Scutt A; Nisbet A
    Age Ageing; 2008 Nov; 37(6):719-20. PubMed ID: 18922834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal study of the motor response to levodopa in Parkinson's disease.
    Clissold BG; McColl CD; Reardon KR; Shiff M; Kempster PA
    Mov Disord; 2006 Dec; 21(12):2116-21. PubMed ID: 17029259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes.
    Tezenas du Montcel S; Clot F; Vidailhet M; Roze E; Damier P; Jedynak CP; Camuzat A; Lagueny A; Vercueil L; Doummar D; Guyant-Maréchal L; Houeto JL; Ponsot G; Thobois S; Cournelle MA; Durr A; Durif F; Echenne B; Hannequin D; Tranchant C; Brice A;
    J Med Genet; 2006 May; 43(5):394-400. PubMed ID: 16227522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenylalanine loading as a diagnostic test for DRD: interpreting the utility of the test.
    Saunders-Pullman R; Blau N; Hyland K; Zschocke J; Nygaard T; Raymond D; Shanker V; Mohrmann K; Arnold L; Tabbal S; deLeon D; Ford B; Brin M; Chouinard S; Ozelius L; Klein C; Bressman SB
    Mol Genet Metab; 2004 Nov; 83(3):207-12. PubMed ID: 15542391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 'Pyruvate dehydrogenase deficiency presenting as dystonia and responding to levodopa'.
    Neubauer D; Frelih J; Zupancic N; Kopac S; Cindro-Heberle L
    Dev Med Child Neurol; 2005 Jul; 47(7):504. PubMed ID: 15991874
    [No Abstract]   [Full Text] [Related]  

  • 51. [Differential diagnosis of essential tremor].
    Ivanova-Smolenskaia IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):321-6. PubMed ID: 7257671
    [No Abstract]   [Full Text] [Related]  

  • 52. Motor fluctuations in Parkinson's disease.
    Weiner WJ
    Rev Neurol Dis; 2006; 3(3):101-8. PubMed ID: 17047575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Focal dystonia. Changing his tune.
    Mettner J
    Minn Med; 2010 Jul; 93(7):10-1. PubMed ID: 20701040
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical aspects on juvenile parkinsonism].
    Ishikawa A
    No To Shinkei; 1994 Jun; 46(6):517-22. PubMed ID: 8068432
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease.
    Stocchi F; Fabbri L; Vecsei L; Krygowska-Wajs A; Monici Preti PA; Ruggieri SA
    Clin Neuropharmacol; 2007; 30(1):18-24. PubMed ID: 17272966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitivity and specificity of a self-administered questionnaire for familial screening of adult-onset dystonia.
    Aniello MS; Martino D; Masi G; Livrea P; Defazio G
    Mov Disord; 2006 Apr; 21(4):571-5. PubMed ID: 16261620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient with limb girdle dystrophy presenting with dopa-responsive dystonia--a case report.
    Verma R; Misra S; Singh NN; Kishore D
    Neurol India; 2003 Jun; 51(2):252-3. PubMed ID: 14571018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Focal hand dystonia, mirror dystonia and motor overflow.
    Sitburana O; Jankovic J
    J Neurol Sci; 2008 Mar; 266(1-2):31-3. PubMed ID: 17888455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Case studies in the advancement of Parkinson's disease.
    Frei K; Truong DD; Wolters E
    CNS Spectr; 2008 Dec; 13(12 Suppl 18):1-6. PubMed ID: 19179948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impaired modulation of motor cortex excitability by homonymous and heteronymous muscle afferents in focal hand dystonia.
    Lourenço G; Meunier S; Vidailhet M; Simonetta-Moreau M
    Mov Disord; 2007 Mar; 22(4):523-7. PubMed ID: 17230472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.